According to the CDC, Shingrix may be used in people with weakened immune systems. At this point, no studies have examined Shingrix in patients with autoimmune disease, cautions Dr. Calabrese. Shingrix includes a compound called an adjuvant that helps the vaccine create a stronger immune response. The adjuvant revs up the immune system, so there is a concern for exacerbating autoimmune diseases, explains Dr. Calabrese. Rheumatologists are awaiting further data on Shingrix in this patient population.
To continue reading this article you must be a paid subscriber
Subscribe to Arthritis Advisor
Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
